As of 10:30 AM on the 10th, Access Bio is trading at 30,800 KRW, up 6.57% from the previous day. This is a 38.09% decrease compared to August 19. Access Bio is known as a specialized manufacturer of in vitro diagnostic products, including malaria diagnostic kits.

Over the past five days, individual investors have net purchased 6,664 shares, while foreigners and institutions have net sold 1,699 shares and 99 shares, respectively.


On September 7, Access Bio became a market topic with the headline "Rising Trend Due to Re-evaluation of COVID-19 Antibody Diagnostic Kits."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing